Robert B. Hinton, MD

Director, Heart Institute BioRepository (HIBR)

Associate Professor, UC Department of Pediatrics

Phone: 513-636-0389

Fax: 513-636-5958


Show All


Clinical Interests

Cardiovascular genetics; echocardiography

Research Interests

Valve and aorta disease using human genetics and molecular developmental biology approaches


Dr. Hinton graduated from Bucknell University with degrees in art history and philosophy. He earned his medical degree from the Medical University of South Carolina in Charleston SC. He completed his pediatric residency training at Memorial Health University Medical Center in Savannah GA and his pediatric cardiology fellowship at Cincinnati Children’s Hospital Medical Center. Dr. Hinton went on to pursue a postdoctoral fellowship in cardiovascular genetics and molecular cardiology at Cincinnati Children’s. He has been an attending staff member of the Division of Cardiology since 2006.

Dr. Hinton’s clinical interests relate to cardiovascular genetics and echocardiography. He is a member of the cardiovascular genetics service, and staffs the echocardiography laboratory. Dr. Hinton’s academic interests focus on translational research efforts using mouse models of human disease to identify new therapeutic targets. Dr. Hinton is a member of the American Academy of Pediatrics, the American Heart Association, the American Society of Bioethics and Humanities, and the American Society of Matrix Biology. He was elected to the Society for Pediatric Research in 2007.

Education and Training

BA: Bucknell University, Lewisburg, PA.

MD: Medical University of South Carolina, Charleston, SC.

Residency: Memorial Health University Medical Center, Savannah, GA.

Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Fellowship: Cincinnati Children's  Research Foundation, Cincinnati, OH.

Certification: Pediatrics, Pediatric Cardiology.


View PubMed Publications


Twist1 regulation of valve progenitors. Co-Investigator. National Heart, Lung and Blood Institute (NIH/NHLBI). Jul 2010-Jun 2015.

Trial of Beta Blocker Therapy (Atenolol) vs. Angiotensin II Receptor Blocker Therapy (Losartan). Co-Investigator. National Heart, Lung and Blood Institute (NIH/NHLBI) Pediatric Heart Network. Sept 2006-Aug 2016.